May 17, 2017, Wednesday

Similar documents
Time Wednesday 17 May 2017 Room. EASO Teaching Courses

NATIONAL COST OF OBESITY SEMINAR. Dr. Bill Releford, D.P.M. Founder, Black Barbershop Health Outreach Program

Smokefree Policies in Europe: Are we there yet?

WCPT COUNTRY PROFILE December 2017 SWEDEN

WCPT COUNTRY PROFILE December 2017 SERBIA

WCPT COUNTRY PROFILE December 2017 HUNGARY

Saturday, June 4, PL7 - EASO Plenary Session: Pros and cons of the diagnosis of Food Addiction for tackling the obesity epidemic

European Community Pharmacy: a reference in Public Health

the high CVD risk smoker

508 the number of suicide deaths in deaths per 100,000 people was the suicide rate in Suicide deaths in 2013 by gender

DECLARATION OF CONFLICT OF INTEREST. None

Engagement in language assessment / Regions of Europe

Models of preventive care in clinical practice to achieve 25 by 25

European Collaboration on Dementia. Luxembourg, 13 December 2006

Overview of drug-induced deaths in Europe - What does the data tell us?

CDR Adult Weight Management Certificate of Training Pre-Course Core and Elective Domains

Real Life, Real PD Survey

Palliative nursing care of children and young people across Europe

Underage drinking in Europe

Alcohol-related harm in Europe and the WHO policy response

WELLNESS COACHING. Wellness & Personal Fitness Solution Providers

Access to treatment and disease burden

European status report on alcohol and health Leadership, awareness and commitment

Cross Border Genetic Testing for Rare Diseases

25 September 2012 Early Years Pathfinder. misuse. Insert name of presentation on Master Slide. Presenter: Dr Sarah J Jones

BACKGROUND AND RATIONALE

Where we stand in EFORT

WESTERN EUROPE PREVALENCE AND INCIDENCE OF PERIPHERAL ARTERY DISEASE AND CRITICAL LIMB ISCHEMIA 2017

Men & Health Work. Difference can make a difference Steve Boorman & Ian Banks RSPH Academy 2013

Table 7.1 Summary information for lung cancer in Ireland,

Manuel Cardoso RARHA Executive Coordinator Public Health MD Senior Advisor Deputy General-Director of SICAD - Portugal

Table 6.1 Summary information for colorectal cancer in Ireland,

PARALLELISM AND THE LEGITIMACY GAP 1. Appendix A. Country Information

TEDDY. Teddy Network of Excellence. Annagrazia ALTAVILLA. Ph.D. Sciences Ethics LL.M. Health Law. diterranée

Prevention of Oral Cancer Special Interest Working Group

CNAPA Meeting Luxembourg September 2016

Inequalities in health: challenges and opportunities in Europe Dr Zsuzsanna Jakab WHO Regional Director for Europe

The health economic landscape of cancer in Europe

Summary of Results for Laypersons

High-Resource Perspective On Adolescent Transition and Research Priorities Ali Judd

Department of Biological Standardisation OMCL Network & Healthcare (DBO)

Burden and cost of alcohol, tobacco and illegal drugs globally and in Europe

Louisville '19 Attachment #69

World Connections Committee (WCC) Report

The Identification of Food Safety Priorities using the Delphi Technique

Current levels and recent trends in health inequalities in the EU: Updates from the EU Report

FOURIER STUDY GREYLOCK PRESS: CTS PRODUCT SAMPLE - FOURIER YES. Did the study achieve its main objective?

Acknowledgement Major Sponsors Principal Sponsors Symposium Sponsor

Design and Analysis of a Cancer Prevention Trial: Plans and Results. Matthew Somerville 09 November 2009

Secondary prevention and systems approaches: Lessons from EUROASPIRE and EUROACTION

Q1 What age are you?

Rheumatoid Arthritis Disease Burden and Access to Treatment

Obesity Management in Primary Care

Undetectable = Untransmittable. Mariah Wilberg Communications Specialist

Joint Programming in Neurodegenerative Disease Research (JPND)

MENTAL HEALTH CARE. OECD HCQI Expert meeting 17 th of May, Rie Fujisawa

Large observational study to UNderstand the Global impact of Severe Acute respiratory FailurE (LUNG-SAFE)

ICMART. International Council of Medical Acupuncture and Related Techniques

Overview of European Consumption Databases

Epidemiology and cost of chronic pain

Perspectives for information on alcohol use in the EU

The influence of societal individualism on a century of tobacco use: modelling the prevalence of smoking Appendices A and B

WELLNESS COACHING. Wellness & Personal Fitness Solution Providers NZ & Australia

The challenge of obesity in the WHO European Region

International Association for the Study of Obesity

European Association of Dental Public Health Prevention of Oral Cancer

EUVAC.NET A surveillance network for vaccine-preventable diseases

PROMOTION AND PROTECTION OF ALL HUMAN RIGHTS, CIVIL, POLITICAL, ECONOMIC, SOCIAL AND CULTURAL RIGHTS, INCLUDING THE RIGHT TO DEVELOPMENT

Allied Health: Sustainable Integrated Health Care for all Australians

EFSA s Concise European food consumption database. Davide Arcella Data Collection and Exposure Unit

31 countries (117 registries, 20 national) Increased coverage in countries with regional registries 50% European population Overall >20 million

Estimating Smoking Related Cause of Death: a Cohort Approach Based on Lung Cancer Mortality in six European Countries

Sperm donation Oocyte donation. Hong Kong þ Guideline þ þ Hungary þ þ þ þ Israel þ þ þ þ Italy þ þ þ. Germany þ þ þ þ Greece þ þ þ þ

Summary of Results for Laypersons

Emerging Risks Mapping of Activities in Member States. 67th Advisory Forum meeting, Utrecht, The Netherlands, 6 February 2018

Fruit & Vegetable Consumption and Mental Health

MEDIA BACKGROUNDER. Teriflunomide: A novel oral drug being investigated for the treatment of Multiple Sclerosis (MS)

European Status report on Alcohol and Health

Tobacco control measures in the Dutch National Prevention Agreement and expected tobacco industry responses

Assisted reproductive technology and intrauterine inseminations in Europe, 2005: results generated from European registers by ESHRE

Monthly measles and rubella monitoring report

Differences make a Difference

Multi-Country Opinion Research Survey TOPLINE RESULTS GLOBAL AVERAGE

IOSH No Time to Lose campaign: working together to tackle asbestos-related cancer #NTTLasbestos. Jonathan Hughes IOSH Vice President

MONKEY. Making a Long Term Difference in Health Care. Copyright 2016 Nutritional Therapy Association, Inc.

Cost of Disorders of the Brain in Europe Gustavsson et al. Cost of disorders of the brain in Europe Eur. Neuropsych. (2011) 21,

Atherosclerotic Cardiovascular Diseases: ischaemic heart disease and stroke

LEBANON. WCPT COUNTRY PROFILE December 2018

A report on the epidemiology of selected vaccine-preventable diseases in the European Region 30% 20% 10%

Present and potential perspectives for information on alcohol use in the EU

Emily J. Hadgkiss, 1 George A. Jelinek, 1,2 Tracey J. Weiland, 1,3 Naresh G. Pereira, 4 Claudia H. Marck, 1 and Dania M.

Current dietary habits in Europe far from plant based eating

Transcription:

EASO Teaching Courses 0830-1230 EASO COTF Teaching Course: Interventions in Childhood Obesity Nobre Chairs: J Baker (Denmark), JC Holm (Denmark) 0830-0845 Welcome and introduction to the session JL Baker (Denmark) 0845-0915 Medical Assessment and Early Detection of Complications JC Holm (Denmark) 0915-0945 How to Assess Pre-diabetes and Diabetes and Treatment Recommendations R Weiss (Israel) 0945-1015 How to Assess Physical Activity and Set-Up Specific Interventions G O Malley (Ireland) 1015-1030 Break 1030-1100 How to Assess Nutrition and Provide Practical Recommendations for the Family M Hassapidou (Greece) 1100-1130 Setting up a Childhood Obesity Clinic: Models, Challenges and Examples N Farpour-Lambert (Switzerland) 1130-1200 Childhood Obesity Treatment: The Portuguese Setting Speaker (Paediatrician) from Porto 1200-1230 How to make the most of practical guidelines: examples and advice Panel

EASO Teaching Courses 0830-1245 EASO OMTF Teaching Course: Multidisciplinary Treatment in Adults Infante Chairs: G Toman (Romania), V Yumuk (Turkey) 0830-0900 Clinical evaluation of the obese patient H Toplak (Austria) 0900-0930 Medical nutrition therapy think tank G Roman (Romania) 0930-1000 The importance of motivational interviewing A Golay (Switzerland) 1000-1030 Creating a hydragenic environment for obesity treatment clinics J Gandy (UK) 1030-1045 Coffee break Chairs: D Dicker (Israel), J Salvador (Spain) 1045-1115 Evidence based physical activity prescriptions M Holecki (Poland) 1115-1145 Pharmacotherapy of obesity D Micic (Serbia) 1145-1215 European guidelines for metabolic surgery M Fried (Czech R) 1215-1245 Postbariatric surgery follow up L Busetto (IItaly)

EASO Teaching Courses 0830-1230 EASO Patient Council Teaching Course: Stigma D.Maria Chairs: D Durrer (Switzerland), C Fleetwood (Sweden) 0900-0910 Presentation of the program and the lecturers... goal setting Chairs 0910-1030 Weight Stigma concepts and theories C Fleetwood (Sweden) 1030-1045 Break 1045-1130 How to apply concepts and theories to our practice and personal behavior A Sharma (Canada) 1130-1200 Evidence-based strategies to support people with obesity towards improved wellbeing while X Ramos-Salas (Canada) also addressing weight stigma. 1200-1215 Discussion and close: We are all in this together Panel

1245-1415 Oral Sessions/Accepted Symposia OS1 1245-1415 Oral Session: Psychology and Behaviour Despachantes Chair: C Hardmann (UK) OS1:OC19 1245-1300 Is food addiction a singular and distinct entity from binge eating? C Long (UK) J Charsley (UK) OS1:OC20 1300-1315 How important is fatness to young children s friendship choices, preferences, and selfidentification? OS1:OC21 1315-1330 Associations between Health-Related Quality of Life and Body Mass Index in Portuguese S Evaristo (Portugal) adolescents: LabMed Physical Activity Study OS1:OC22 1330-1345 Patterns of Public Opinions about Obesity and People with Obesity in Sweden, UK, Germany, T K Kyle (US) and Italy OS1:OC23 1345-1400 Bidirectional associations between psychosocial well-being and adherence to healthy dietary L Arvidsson (Sweden) guidelines in European children: prospective findings from the IDEFICS study OS1:OC24 1400-1415 Tracking diet variety in childhood and its association with appetitive traits S Vilela (Portugal)

1245-1415 Oral Sessions/Accepted Symposia OS2 1245-1415 Oral Session: Metabolic Outcomes Nobre Chairs: M Blüher (Germany), M Holecki (Poland) 1245-1300 Effects of prenatal exposure to cigarette smoke on adiposity, physical activity patterns, and D Cameron (Canada) resting energy expenditure in young children OS2:OC50 1300-1315 MRI-fat quantification of the liver, subcutaneous and visceral fatty tissue and correlation with B Wölnerhanssen (Switzerland) blood lipids in patients before and after bariatric surgery OS2:OC51 1315-1330 Effect of a lifestyle intervention in obese infertile women on cardiometabolic health and quality of life L van Dammen (Netherlands) OS2:OC52 1330-1345 Changes in physical fitness, hepatic markers, and insulin resistance after an 8-months E Silva (Brasil) multicomponent intervention program with Down syndrome adolescents. OS2:OC53 1345-1400 A randomised controlled trial assessing the impact of intermittent vs continuous energy restriction A Pinto (UK) on blood pressure and anthropometry in healthy subjects with central obesity. The Met-IER Study OS2:OC54 1400-1415 Metabolically healthy obese and incident cardiovascular disease events among 3.5 million men R Caleyachetty (UK) and women in the UK

1245-1415 Oral Sessions/Accepted Symposia 1245-1415 Accepted Symposium: Is it Time to Integrate Obesity Surgery within the Frames of Childhood Infante Obesity Treatment? Chair: C Marcus (Sweden) 1245-1305 Long-term effects of bariatric surgery in adolescents T Inge (US) 1305-1325 Psychological outcomes after bariatric surgery in adolescents K Järvholm (Sweden) 1325-1345 Reasons against bariatric surgery in adolescents what are the alternatives? R Weiss (Israel) 1345-1415 Discussion

1245-1415 Oral Sessions/Accepted Symposia OS3 1245-1415 Oral Session: Adipose Tissue Biology D. Maria Chairs: E Blaak (Netherlands), C Calhau (Portugal) OS3:OC1 1245-1300 The actions of elevated BNP on adipose tissue adaptations during chronic pressure overload G Almeida (Portugal) OS3:OC2 1300-1315 Insulin resistance is associated with a specific methylation profile of visceral adipose tissue in A González-Izquierdo (Spain) obese patients OS3:OC3 1315-1330 Ethnic differences in body fat distribution and the relationship with adipose tissue oestrogen D Keswell (South Africa) receptor expression OS3:OC4 1330-1345 Unbalanced proteostasis in preadipocytes in obesity-related type 2 diabetes J Sánchez-Ceinos (Spain) OS3:OC5 1345-1400 Alpha-MSH induces browning of subcutaneous white adipose tissue in mice A Rodrigues (Portugal) OS3:OC6 1400-1415 Involvement of the dermal white adipose tissue in cutaneous wound healing delay during A Begey (France) obesity

1430-1600 Review/Workshop Sessions RS1 1430-1600 Size matters: How can Big Data Help Obesity D. Luis Chairs: T Handjieva-Darlenska (Bulgaria), H Hauner (Germany) RS1:1 1430-1500 How to make the most out of big data: Best practice examples I Arts (Netherlands) RS1:2 1500-1530 Personalised nutrition and prediction of glycaemic responses D Zeevi (Israel) RS1:3 1530-1545 The Body Composition Profile Enhancing the Understanding of Obesity using UK Biobank O Leinhard (Sweden) Imaging Data RS1:4 1545-1600 Metabolic profiling of tissue-specific insulin resistance in human obesity N Vogelzangs (Netherlands)

1430-1600 Review/Workshop Sessions RS2 1430-1600 A Year in Adipose Tissue: Novel Players and Future Treatments in WAT and BAT Biology Nobre Chairs: G Goossens (Netherlands), M Monteiro (Portugal) RS2:1 1430-1500 FGF21 and energy balance F Villarroya (Spain) RS2:2 1500-1530 Plasticity of Adipose Tissue F Karpe (UK) RS2:3 1530-1545 Calorie restriction decreases thermogenic potential of subcutaneous WAT in humans. V Barquissau (France) RS2:4 1545-1600 Adipocyte hypertrophy and associated inflammatory phenotype as major determinants of K Verboven (Netherlands) insulin resistance in male obese humans

1430-1600 Review/Workshop Sessions RS3 1430-1600 Loss versus Maintenance: The False Dichotomy Infante Chairs: B Heitmann (Denmark), G Roman (Romania) RS3:1 1430-1500 Predictors of weight regain after moderate diet-induced weight loss M van Baak (Netherlands) RS3:2 1500-1530 Long term wight loss maintenance for obesity: a mutidisciplinary appraoch P Sbraccia (Italy) RS3:3 1530-1545 Early responders to liraglutide 3.0 mg as adjunct to diet and exercise from the SCALE S Wharton (Canada) Maintenance trial RS3:4 1545-1600 Long-term follow-up (4 years) of patients receiving cognitive behavioural therapy (CBT) or usual H Gade (Norway) care before bariatric surgery: A randomized controlled trial

1430-1600 Review/Workshop Sessions RS4 1430-1600 Population Based Approaches D. Maria Chairs: C Lopez (Portugal), T Visscher (Netherlands) RS4:1 1430-1500 Regulation around the food environment (portion size, labelling, fiscal) T Lobstein (UK) RS4:2 1500-1530 Global Active Cities G Messmer (Switzerland) RS4:3 1530-1600 Population approaches J Lakerveld (Netherlands)

1800-1945 Plenary Session/Opening Ceremony PL1 1800-1900 Opening Plenary: Obesity as a disease Despachantes Chairs: D Carvalho (Portugal), P Freitas (Portugal), H Toplak (Austria) 1800-1820 The WHO view of Obesity as a disease J Breda (Portugal) PL1:2 1820-1840 The challenges in defining obesity K Schindler (Austria) PL1:3 1840-1900 Beyond cardiometabolic disease: the myth of healthy obesity M Blüher (Germany) 1900-1945 ECO2017 Opening Ceremony Despachantes Chairs: D Carvalho (Portugal), P Freitas (Portugal), H Toplak (Austria)